Cover Image

Safety and immunogenicity of heterologous Ad26.ZEBOV and MVA-BN®-Filo prime-boost Ebola vaccines: 6-month follow-up of a Phase I randomized trial in healthy adults

Saved in:

Bibliographic Details
Main Authors:	Macaya Douoguih (Author), Neil Goldstein (Author), Stephan Bart (Author), Kerstin Luhn (Author), Wilbert Van Duijnhoven (Author), Carla Truyers (Author), Benoit Callendret (Author)
Format:	Book
Published:	Elsevier, 2016-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Helminth exposure and immune response to the two-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccine regimen.
by: Houreratou Barry, et al.
Published: (2024)

Lot-to-lot consistency, immunogenicity, and safety of the Ad26.ZEBOV, MVA-BN-Filo Ebola virus vaccine regimen: A phase 3, randomized, double-blind, placebo-controlled trial
by: Neil Goldstein, et al.
Published: (2024)

A two-dose heterologous prime-boost vaccine regimen eliciting sustained immune responses to Ebola Zaire could support a preventive strategy for future outbreaks
by: Georgi Shukarev, et al.
Published: (2017)

Implementation of accelerated research: strategies for implementation as applied in a phase 1 Ad26.ZEBOV, MVA-BN-Filo two-dose Ebola vaccine clinical trial in Uganda
by: Jonathan Kitonsa, et al.
Published: (2020)

Heterologous Prime-boost COVID-19 Vaccination
by: Vishal R. Tandon, et al.
Published: (2021)

TLR1/2 activation during heterologous prime-boost vaccination (DNA-MVA) enhances CD8+ T Cell responses providing protection against Leishmania (Viannia).
by: Asha Jayakumar, et al.
Published: (2011)

Vaccines against mpox: MVA-BN and LC16m8
by: John D. Grabenstein, et al.
Published: (2024)

Heterologous prime-boost vaccination against COVID-19: is it safe and reliable?
by: Om Prakash Choudhary, et al.
Published: (2021)

Is heterologous prime-boost COVID-19 vaccination a concern or an opportunity for Ethiopia?
by: Tesfaye Gelanew, et al.
Published: (2023)

Equivalence of freeze-dried and liquid-frozen formulations of MVA-BN as smallpox and mpox vaccine
by: Richard N. Greenberg, et al.
Published: (2024)

Heterologous boosting with recombinant VSV-846 in BCG-primed mice confers improved protection against Mycobacterium infection
by: Ming Zhang, et al.
Published: (2017)

A Heterologous Multiepitope DNA Prime/Recombinant Protein Boost Immunisation Strategy for the Development of an Antiserum against Micrurus corallinus (Coral Snake) Venom.
by: Henrique Roman Ramos, et al.
Published: (2016)

Immunogenicity and safety of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine: a systematic review
by: Jingjing Lv, et al.
Published: (2022)

Immunogenicity and reactogenicity after heterologous prime-boost vaccination with CoronaVac and ChAdox1 nCov-19 (AZD1222) vaccines
by: Guy Cohen, et al.
Published: (2022)

Heterologous vaccine interventions: boosting immunity against future pandemics
by: Daniela Marín-Hernández, et al.
Published: (2021)

Mix-and-Match COVID-19 Vaccinations (Heterologous Boost): A Review
by: Ishan Garg, et al.
Published: (2022)

An evaluation of cytokine and cellular immune responses to heterologous prime-boost vaccination with influenza A/H7N7-A/H7N9 inactivated vaccine
by: Hana M El Sahly, et al.
Published: (2020)

Novel prime-boost vaccine strategies against HIV-1
by: Jean-Louis Excler, et al.
Published: (2019)

Immunogenicity and reactogenicity of heterologous prime-boost vaccination with inactivated COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccines, a quasi-experimental study
by: Kriangkrai Tawinprai, et al.
Published: (2023)

Safety, immunogenicity and immune-persistence of heterologous prime-boost immunization with BBIBP-CorV and ZF2001 against SARS-CoV-2 in healthy adults aged 18 years or older
by: Yingping Chen, et al.
Published: (2023)

Effectiveness of heterologous ChAdOx1 nCoV-19 and mRNA prime-boost vaccination against symptomatic Covid-19 infection in Sweden: A nationwide cohort study
by: Peter Nordström, et al.
Published: (2021)

Multilingüismo, arma de doble filo
by: Janeth Lasso Avendaño
Published: (2018)

Al filo de la navaja
by: Bernard Lavallé
Published: (2002)

Durability of single-dose rVSV-ZEBOV vaccine responses: what do we know?
by: Angela Huttner, et al.
Published: (2018)

Dynamics of 8G12 competitive antibody in "prime-boost" vaccination of Hepatitis E vaccine
by: Xing Wu, et al.
Published: (2017)

Priming Mesenchymal Stem Cells with Lipopolysaccharide Boosts the Immunomodulatory and Regenerative Activity of Secreted Extracellular Vesicles
by: Aina Areny-Balagueró, et al.
Published: (2024)

A 2-Year-Old Victim of an MVA
by: Kathleen Ventre
Published: (2010)

Per filo e per segno L'arte della lana a Firenze nel Cinquecento
by: Ammannati, Francesco
Published: (2020)

Per filo e per segno L'arte della lana a Firenze nel Cinquecento
by: Ammannati, Francesco
Published: (2020)

Ebola virus glycoprotein needs an additional trigger, beyond proteolytic priming for membrane fusion.
by: Shridhar Bale, et al.
Published: (2011)

Memoria e interpretación de Al filo del agua
by: Zavala Díaz, Ana Laura
Published: (2000)

More robust gut immune responses induced by combining intranasal and sublingual routes for prime-boost immunization
by: Hye Suk Hwang, et al.
Published: (2018)

Immunogenicity and persistence of a prime-boost re-vaccination strategy for pneumococcal vaccines in patients with rheumatoid arthritis
by: Mathilde Bahuaud, et al.
Published: (2018)

Poxviral promoters for improving the immunogenicity of MVA delivered vaccines
by: Naif Khalaf Alharbi
Published: (2019)

The dynamics of immunoglobulin V-gene usage and clonotype expansion in mice after prime and boost immunizations as analyzed by NGS
by: Diego J. Farfán-Arribas, et al.
Published: (2017)

Priming Mesenchymal Stem Cells with Endothelial Growth Medium Boosts Stem Cell Therapy for Systemic Arterial Hypertension
by: Lucas Felipe de Oliveira, et al.
Published: (2015)

Multi-stage subunit vaccines against Mycobacterium tuberculosis: an alternative to the BCG vaccine or a BCG-prime boost?
by: Farzad Khademi, et al.
Published: (2018)

Sequential administration of MVA-based vaccines and PD-1/PD-L1-blocking antibodies confers measurable benefits on tumor growth and survival: Preclinical studies with MVA-βGal and MVA-MUC1 (TG4010) in a murine tumor model
by: Christelle Remy-Ziller, et al.
Published: (2018)

La educación secundaria en México: al filo de su reforma
by: Margarita Zorrilla
Published: (2016)

Testing the efficacy of a multi-component DNA-prime/DNA-boost vaccine against Trypanosoma cruzi infection in dogs.
by: José E Aparicio-Burgos, et al.
Published: (2011)